ClinicalTrials.gg
RecruitingNCT06094218Updated Oct 16, 2026

Development of a Treatment Prognosis Calculator for the Prevention of Suicide

An interventional study of Brief Cognitive Behavioral Therapy (BCBT) and Treatment as usual (TAU) in Suicidal Ideation, sponsored by Ohio State University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Ohio State University · Not applicable, Interventional, and Prevention

How we know

Updated Oct 16, 2026Start date movedPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
1,200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Suicidal Ideation by Ohio State University — 5 open to participants now, 5 under way, none of them phase 3. Suicidal Ideation · Ohio State University.

Planned enrollment
Largest of 10
1,200 · median 99
Started
2026
with 2 others
No phase
10 of 10
5 open now
Registered
7th of 10
by date

Among the 10 studies in Suicidal Ideation by Ohio State University, this one has the largest planned enrollment, is one of 3 that started in 2026, is one of 10 with no phase, and was the 7th registered.

Suicidal Ideation

570 studies on the registry are indexed under Suicidal Ideation; 204 are open to participants now.

Browse Suicidal Ideation studies →

Open to participants now

5 of the 10 studies in Suicidal Ideation by Ohio State University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 135 Suicidal Ideation studies recruiting now, 52 (39%) set no upper age limit and 79 (59%) stop at 75 or younger; 54 take children under 18; 32 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Suicidal Ideation by Ohio State University, or all of them as a file.
02

Study summary

The goal of this interventional study is to develop and test a treatment prognosis calculator to identify which service members with suicidal ideation or behavior are likely to respond well to the current standard of care treatment and which should instead receive Brief Cognitive Behavioral Therapy (BCBT) as a first-line treatment.

The main aims of the study are:

  • Aim 1: To develop a novel treatment prognostic calculator to predict response to treatment as usual (TAU) and identify treatment-seeking military personnel who are unlikely to respond adequately to TAU for the reduction of suicidal ideation.
  • Aim 2: To evaluate the performance of the treatment prognosis calculator in a new sample of treatment-seeking military personnel and determine whether BCBT is more effective than TAU for those patients who are predicted not to respond adequately to TAU.

Participants will receive mental health treatment as it is typically administered by their mental healthcare treatment team. Members of their mental healthcare treatment team may receive intensive training in BCBT. After their provider has received this training, they may use this treatment as part of standard of care treatment. The timing of this training will be determined randomly. Participants will complete self-report assessments at the beginning of the study (baseline) as well as 3, 6, 9 and 12 months after their participant begins. These assessments will include questions about feelings, thoughts, moods, impulses, substance use, and behavior.

03

Conditions studied

  • Suicidal Ideation

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. female and male active duty service members;
  2. => 18 years old;
  3. engaged in mental health treatment at one of the sites at study enrollment;
  4. score >0 on the Columbia Suicide Severity Rating Scale (CSSRS) Screener-Recent, or indicated suicidal ideation on questions 4 or 5 of the Scale for Suicidal Ideation, indicating suicidal ideation within the last month;
  5. able to understand and speak English;
  6. able to provide consent.

Exclusion criteria

Exclusion Criteria:

(1) participants with a psychiatric or medical condition that prevents them from providing or from participating in the treatments (e.g., psychosis, mania, acute intoxication).

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
1,200 participants (estimated)

Study arms

  • Active comparator
    Treatment as Usual (TAU)

    TAU may include (1) routine suicide risk screening and assessment; (2) safety planning with means restriction; and (3) the Collaborative Assessment and Management of Suicidality (CAMS), an evidence-based approach to managing and treating suicidal patients.

    Behavioral: Treatment as usual (TAU)

  • Experimental
    Brief Cognitive Behavioral Therapy (BCBT)

    BCBT consists of 12 outpatient individual psychotherapy sessions scheduled weekly or biweekly. The first session is 90 minutes and subsequent sessions are 60 minutes. BCBT is divided into three phases. In phase 1 (5 sessions), the therapist conducts a detailed assessment of the patient's most recent suicidal episode or suicide attempt, identifies patient-specific factors that contribute to and maintain suicidal behaviors, provides a cognitive-behavioral conceptualization, collaboratively develops a crisis response plan, and teaches basic emotion regulation skills. In phase 2 (5 sessions), the therapist teaches cognitive restructuring skills to build cognitive flexibility. In phase 3 (2 sessions), a relapse prevention task is conducted, and participants must demonstrate the ability to successfully complete this task in order to terminate the treatment. Additional sessions are conducted until participants demonstrate the ability to successfully complete this task.

    Behavioral: Brief Cognitive Behavioral Therapy (BCBT)

Interventions

  • BehavioralBrief Cognitive Behavioral Therapy (BCBT)

    BCBT was developed to provide patients with the skills they need to better manage the cognitive, emotional, physiological, and behavioral components of acute suicidal crises.

  • BehavioralTreatment as usual (TAU)

    Behavioral health treatment as it is typically provided at the treatment site.

06

What researchers measure

Primary outcomes

  1. Suicidal Ideation

    Assess severity of suicidal ideation at 6 months with the Scale for Suicide Ideation (SSI)

    Time frame: 6 Months

Secondary outcomes

  1. Suicide Attempts

    Suicide attempts will be assessed with the Self-Injurious Thoughts and Behaviors Interview-Revised (SITBI-R)

    Time frame: 12 Months

  2. Depression

    Depression will be assessed with the PROMIS-Depression Computer Adaptive Test (CAT)

    Time frame: 12 Months

  3. Hopelessness

    Hopelessness will be assessed with the abbreviated Beck Hopelessness Scale (BHS)

    Time frame: 12 Months

07

Study locations

1 of 1 sites recruiting
  • Harding Hospital
    Columbus, Ohio 43210, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2028, 24 months later.

Of 282 non-industry interventional studies with no phase under Suicidal Ideation, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 54. This study's planned 24 months is below that.

Counting every sponsor, half of 291 studies reached it within 30 months; a quarter within 13 and three quarters within 54.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: start Oct 2023 → Oct 2026, primary completion Aug 2026 → Oct 2028 and completion Aug 2027 → Aug 2029.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 3, 2023
First posted
Oct 23, 2023
StartEst.
Oct 31, 2026was Oct 2023
Primary completionEst.
Oct 31, 2028was Aug 2026
CompletionEst.
Aug 31, 2029was Aug 2027
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Oct 31, 2023→Oct 31, 2026
Oct 16, 2026
Primary completion
Aug 31, 2026→Oct 31, 2028
Oct 16, 2026
Study completion
Aug 31, 2027→Aug 31, 2029
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Start date Oct 31, 2023→Oct 31, 2026
    Primary completion Aug 31, 2026→Oct 31, 2028
    Study completion Aug 31, 2027→Aug 31, 2029

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06094218
Collaborators
United States Department of Defense
Responsible party
Jay Fournier (Associate Professor, Department of Psychiatry & Behavioral Health, Ohio State University) — Principal investigator
First posted
Oct 23, 2023
Start date
Oct 31, 2026 (estimated)
Primary completion
Oct 31, 2028 (estimated)
Completion
Aug 31, 2029 (estimated)
Last update
Oct 16, 2026

Study contacts

Jay Fournier, PhD
Contact
jay.fournier@osumc.edu
614-293-9889

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion